• Home
• estrogen nausea
• An emerging generation of endocrine therapies in breast cancer: a clinical perspective

An emerging generation of endocrine therapies in breast cancer: a clinical perspective

4.7 (66) · $ 9.00 · In stock

Oncology - European Medical Journal

Emerging Endocrine Therapies for the Management of Breast Cancer

CRISPR Clinical Trials: A 2023 Update - Innovative Genomics

Book - Therapeutic Drug Targets and Phytomedicine For Triple

Cancers, Free Full-Text

Inclusion and exclusion criteria.

Novel endocrine therapies: What is next in estrogen receptor

Role of the gut microbiota in tumorigenesis and treatment

EMJ Oncology 11.1 2023 by European Medical Journal - Issuu

ZB716, a steroidal selective estrogen receptor degrader (SERD), is

Current and Upcoming Treatment Strategies After CDK4/6 Inhibitors

Cancers, Free Full-Text

HER2 and Breast Cancer — A Phenomenal Success Story